Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 1250

BillFederalSenateIn Committee
A bill to prioritize funding for an expanded and sustained national investment in biomedical research.
About This Bill
Committee
Latest Action · April 30, 2019
Read twice and referred to the Committee on the Budget. (text: CR S2521-2522)
Congress
116th (2019–2021)
Introduced
April 30, 2019
Sponsor
Sen. Richard DurbinD
Cosponsors (8)
8D 0R
View PDF ↗

Summary

Highlight any text to annotate
American Cures Act This bill requires certain adjustments to discretionary spending limits over FY2020-FY2024 to accommodate increases in appropriations for agencies that perform biomedical research. Adjustments are required for the National Institutes of Health, the Centers for Disease Control and Prevention, the Department of Defense health program, and the Department of Veterans Affairs medical and prosthetics research program. The bill also requires annual appropriations in FY2020-FY2024 for each of the programs and agencies referenced in this bill to be at least the amount appropriated for FY2019. The bill exempts appropriations provided pursuant to this bill from sequestration. Sequestration is a process of automatic, usually across-the-board spending reductions under which budgetary resources are permanently cancelled to enforce specific budget policy goals.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.